Q4 2013 13F Holders as of 12/31/2013
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
157M
-
Number of holders
-
41
-
Total 13F shares, excl. options
-
7.13M
-
Shares change
-
0
-
Total reported value, excl. options
-
$27.8M
-
Value change
-
$0
-
Price
-
$3.90
Significant Holders of TG THERAPEUTICS, INC. - Common Stock (TGTX) as of Q4 2013
43 filings reported holding TGTX - TG THERAPEUTICS, INC. - Common Stock as of Q4 2013.
TG THERAPEUTICS, INC. - Common Stock (TGTX) has 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.13M shares
of 157M outstanding shares and own 4.54% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (2.2M shares), BRIDGER MANAGEMENT, LLC (1.65M shares), VANGUARD GROUP INC (673K shares), JENNISON ASSOCIATES LLC (455K shares), BlackRock Fund Advisors (448K shares), NORTHERN TRUST CORP (213K shares), Smith Asset Management Group LP (197K shares), COLUMBUS CIRCLE INVESTORS (162K shares), State Street Corp (143K shares), and BlackRock Institutional Trust Company, N.A. (137K shares).
This table shows the top 41 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.